However, the robust anti-tumor activity displayed by these CAR T cells was associated with induction of cachexia in animal models that requires specific strategies to reduce cytokine toxicity, such as administration of anti-TNFα antibody or selection of low cytokine producing T lymphocytes [159]. The gene discussed is TNF; the disease is neoplasm.